2009 - Member of the National Academy of Medicine (NAM)
Dana P. Goldman focuses on Health economics, Gerontology, Health care, Public health and Life expectancy. Her research in Health economics intersects with topics in Demography, Medicaid, Retrospective cohort study, Geriatrics and Cost sharing. The various areas that Dana P. Goldman examines in her Gerontology study include Obesity, Clinical trial, Cohort study, Disease and Race and health.
Her research in Health care focuses on subjects like Environmental health, which are connected to Social determinants of health, MEDLINE, Actuarial science and Health spending. She focuses mostly in the field of Public health, narrowing it down to topics relating to Family medicine and, in certain cases, Hiv infected and Physical therapy. Dana P. Goldman works mostly in the field of Life expectancy, limiting it down to topics relating to Longevity and, in certain cases, Population ageing and Censoring.
Dana P. Goldman spends much of her time researching Health care, Health economics, Actuarial science, Family medicine and Gerontology. Her work carried out in the field of Health care brings together such families of science as Nursing, Life expectancy, Public economics and Demographic economics. Dana P. Goldman interconnects Social security and Longevity in the investigation of issues within Life expectancy.
Her Health economics research incorporates elements of Health insurance, Pharmacy and Geriatrics. Dana P. Goldman has researched Actuarial science in several fields, including Moral hazard, Medicare Part D, Prescription drug and Payment. Her research in Gerontology intersects with topics in Health equity, Socioeconomic status and Disease.
Her primary areas of investigation include Health care, Demography, Life expectancy, Gerontology and Internal medicine. Her study in Health economics and Managed care are all subfields of Health care. Her study in Health economics is interdisciplinary in nature, drawing from both Public economics, Cohort study, Development economics, Productivity and Population health.
Her work carried out in the field of Demography brings together such families of science as Cancer, Fee-for-service, Disease, Lung cancer and Cohort. Her research integrates issues of Demographic economics, Successful aging, Population ageing, Social security and Longevity in her study of Life expectancy. Her Gerontology research incorporates themes from Quality-adjusted life year, National Health and Nutrition Examination Survey and Geriatrics.
Dana P. Goldman mainly focuses on Health care, Demography, Gerontology, Life expectancy and Disease. Her Health care research focuses on Public health and how it relates to Nursing research, Sobriety, Hepatitis C and Mexican Health and Aging Study. She integrates many fields, such as Gerontology and Perspective, in her works.
Her Disease research integrates issues from Cost–benefit analysis, Incidence, Health economics, Type 1 diabetes and Purchasing. Her biological study spans a wide range of topics, including Optimism, Public economics, Managed care, Financial incentives and Population health. Dana P. Goldman has included themes like Pharmacy, Retrospective cohort study, Cohort study and Emergency medicine in her Cost sharing study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
Joy H. Lewis;Meredith L. Kilgore;Dana P. Goldman;Edward L. Trimble.
Journal of Clinical Oncology (2003)
Prescription drug cost sharing: associations with medication and medical utilization and spending and health.
Dana P. Goldman;Geoffrey F. Joyce;Yuhui Zheng.
JAMA (2007)
Variations in the Care of HIV-Infected Adults in the United States: Results From the HIV Cost and Services Utilization Study
M F Shapiro;S C Morton;D F McCaffrey;J W Senterfitt.
JAMA (1999)
Differences in life expectancy due to race and educational differences are widening, and many may not catch up.
S. Jay Olshansky;Toni C. Antonucci;Lisa F. Berkman;Robert H. Binstock.
Health Affairs (2012)
Pharmacy Benefits and the Use of Drugs by the Chronically Ill
Dana P. Goldman;Geoffrey F. Joyce;Jose J. Escarce;Jennifer E. Pace.
JAMA (2004)
Can patient self-management help explain the SES health gradient?
Dana Goldman;James Smith.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy
Samuel A. Bozzette;Samuel A. Bozzette;Samuel A. Bozzette;Geoffrey Joyce;Daniel F. McCaffrey;Arleen A. Leibowitz;Arleen A. Leibowitz.
The New England Journal of Medicine (2001)
Access of Vulnerable Groups to Antiretroviral Therapy Among Persons in Care for HIV Disease in the United States
R Andersen;S Bozzette;M Shapiro;P St Clair.
Health Services Research (2000)
Are The Young Becoming More Disabled
Darius Noshir Lakdawalla;Jayanta Bhattacharya;Dana Goldman.
Health Affairs (2004)
Employer Drug Benefit Plans and Spending on Prescription Drugs
Geoffrey F. Joyce;José J. Escarce;Matthew D. Solomon;Dana P. Goldman.
JAMA (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Southern California
RAND Corporation
University of Southern California
Stanford University
University of California, Los Angeles
Cornell University
Harvard University
University of California, Los Angeles
University of California, San Diego
University of Southern California
Korea Advanced Institute of Science and Technology
Polytechnic University of Milan
Facebook (United States)
Alibaba Group (China)
Indian Institute of Science
Federal University of Toulouse Midi-Pyrénées
Yale University
Indira Gandhi Centre for Atomic Research
Kansas State University
University of Padua
United States Geological Survey
Pablo de Olavide University
Stanford University
Jönköping University
University of Warwick
Mayo Clinic